Click on any press release to download the pdf
- The Leukemia & Lymphoma Society® and Onconova Therapeutics, Inc. Enter Partnership to Advance Clinical Development of ESTYBON™ in High Risk Myelodysplastic Syndrome Patients White Plains, NY and Newtown, PA
-- June, 1, 2010 - Onconova Highlights Data on Novel Mechanism and Pharmacokinetics of Lead Compound ON 01910.Na at AACR in Washington, DC
-- April 17-21, 2010 - Onconova Therapeutics to Present at the 28th Annual J.P. Morgan Healthcare and Biotech Showcase Conferences
-- January 12th and 14th, 2010 - Onconova Therapeutics Announces Presentation of Clinical Proof of Concept of ON 01910.Na in Patients with Hight Risk Myelodysplastic Syndrome (MDS) at ASH 2009 Annual Meeting
--December 7, 2009 - Onconova Therapeutics Announces Presentation of Nonclinical Data on Lead Compound ON 01910.Na and New Jak 2/Bcr-abl Inhibitors at AACR
--April 21, 2009 - Onconova Therapeutics Announces Initiation of Phase I Clinical Testing for Ex-RADTM, a Radioprotective Drug
--January 23, 2009 - Onconova and DoD Collaborators Publish Research Demonstrating Increased Survivability of Previously Lethal Radiation in Mice with New Radioprotective Drug Ex-RADTM
--January 23, 2009 - Onconova Therapeutics Announces Publication of Positive Phase I Results for Lead Anticancer Compound in Journal of Clinical Oncology
--October 28, 2008 - Onconova Therapeutics Announces Presentation of Clinical and Nonclinical Data on Lead Compound ON 01910.Na and New Sulfonamide Compounds at AACR
--April 11, 2008 - Onconova Therapeutics Announces Presentation of Clinical and Non-Clinical Results for Its Lead Compound ON 01910.Na at American Association of Cancer Research Conference in Los Angeles
Onconova Founder Dr. E. Premkumar Reddy Honored
--April 16, 2007 - Data Presented on Anti-Cancer Compound ON 01910.Na at American Society of Clinical Oncology (ASCO) Conference
--June 5, 2006 - Michael Hoffman is Elected Chairman of the Board for Onconova
--May 30, 2006 - Dr. Jerome Groopman Chairs Onconova Therapeutics Inc. New Clinical Advisory Board
-Board to Advice Development Team that Spearheaded Recent Publications on Discovery of Novel Kinase Inhibitors in Two Leading Journals
--March 23, 2005 - Onconova Therapeutics Begins Phase I Clinical Trial of Anti-Cancer Agent
--July 26, 2004